What is the recommended starting dose of risperidone for an adult with schizophrenia?

Starting Dose for Risperidone in Adult Schizophrenia

For adults with schizophrenia, start risperidone at 2 mg per day, which can be given as a single daily dose or divided into twice-daily dosing. 1

Dosing Algorithm

Initial Dosing

• Starting dose: 2 mg/day (either once daily or 1 mg twice daily) 1
• This FDA-approved starting dose applies to most adult patients with schizophrenia
• In some patients, slower titration may be appropriate 1

Titration Schedule

• Increase at intervals of 24 hours or greater in increments of 1-2 mg/day as tolerated 1
• Target dose: 4-8 mg/day 1
• The most recent international guidelines (2025) recommend 2 mg/day as an appropriate initial target dose for most patients 2

Optimal Therapeutic Range

The evidence strongly supports 4-6 mg/day as the optimal dose range for most patients:

• Doses of 4 mg/day and 6 mg/day demonstrate the best balance of efficacy and tolerability 3, 4, 5
• Research shows that 6 mg/day was as effective as 16 mg/day but with significantly fewer extrapyramidal symptoms 4
• PET studies measuring dopamine D2 receptor occupancy suggest 4 mg/day achieves optimal receptor binding (70-80% occupancy) with minimal risk of extrapyramidal side effects 6
• Doses above 6 mg/day were not more efficacious than lower doses and caused more adverse effects 1, 3

Special Populations

First-Episode Psychosis

• Start at 2 mg/day as the initial target dose 7
• Early psychosis guidelines specifically recommend this lower starting approach
• Maximum dose typically 4-6 mg/day in first-episode patients 7
• Slower titration is particularly important in this population to minimize side effects and encourage adherence

Elderly or Medically Compromised Patients

• Start at 0.5 mg twice daily (1 mg/day total) 1
• This applies to patients with severe renal or hepatic impairment
• May increase to dosages above 1.5 mg twice daily at intervals of one week or longer 1

Adolescents (13-17 years)

• Start at 0.5 mg once daily 1
• Increase in increments of 0.5-1 mg/day as tolerated
• Target dose: 3 mg/day (effective range 1-6 mg/day) 1

Critical Considerations

Why Not Start Higher?

The evidence clearly shows that starting at doses of 6 mg/day or higher (as was done in early trials) leads to unnecessarily high D2 receptor occupancy (>80%) and increased extrapyramidal symptoms 6. The 2 mg starting dose allows for:

• Better tolerability during initial treatment
• Reduced risk of early discontinuation due to side effects
• Ability to titrate upward based on individual response

Assessment Timeline

• Evaluate response after at least 4 weeks at therapeutic dose 8, 2
• If inadequate response after 4 weeks at adequate dose with confirmed adherence, consider switching to alternative antipsychotic 2
• Do not increase dose more frequently than every 24 hours during initial titration 1

Common Pitfalls to Avoid

1. Starting too high: The original trials used 6 mg/day as a starting target, but this is now known to be excessive for most patients 9, 6
2. Titrating too rapidly: Allow at least 24-hour intervals between dose increases 1
3. Exceeding 6 mg/day without clear justification: Higher doses increase side effects without improving efficacy 3, 4, 5
4. Not accounting for renal/hepatic impairment: These patients require 0.5 mg twice daily starting dose 1

Monitoring During Titration

• Assess for extrapyramidal symptoms, particularly as dose approaches or exceeds 6 mg/day 1
• Monitor orthostatic vital signs, especially during initial dose titration 1
• Document target symptoms and treatment response 8